Navigation Links
New prostate cancer research findings
Date:10/4/2007

WHAT: The 2007 Prostate Cancer Foundation Scientific Retreat will feature new studies by the worlds leading researchers in prostate cancer. Presentations include discoveries expected to lead to new diagnostics and treatments, and the potential to help men avoid developing prostate cancer.

SELECTED PANELS INCLUDE:

  • Lifestyle Navigation: Researchers will share new research on how eating common foods such as tomatoes and fish, maintaining a healthy weight, and avoiding meats cooked at high temperatures may help prevent prostate cancer, and help men live healthier and longer after diagnosis. More widespread studies, in combination with newer technologies in gene research, are substantiating some long-held hypotheses
    (Embargoed until 1:00pm EDT Saturday, October 13th)
  • Epigenetics: Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
    (Embargoed until 11:15pm EDT Thursday, October 11th)
  • Intracrine androgens: Cancer researchers have long worked to understand why some prostate cancers recur after the use of therapies designed to stop the production of testosterone and other androgens that fuel cancer cell growth. New research has now detected that androgen-synthesizing proteins are present within cancer cells, which suggests that cancer cells may develop the capacity to produce their own androgens. The presence of these proteins may explain why some prostate cancers become resistant to these widely-used therapies, and offers new directions for research into treatments to block the development of these androgens in cancer cells.
    (Embargoed until 6:00pm EDT October 11th)

WHO: The Prostate Cancer Foundation (PCF) is the world's largest philanthropic source of support for prostate cancer research. Founded in 1993, the PCF has raised more than $300 million and provided funding for prostate cancer research to more than 1,400 researchers at 100 institutions worldwide. The PCF has a simple, yet urgent goal: to find better treatments and a cure for recurrent prostate cancer. For more information, visit www.prostatecancerfoundation.org.

WHEN: October 11-13, 2007, Lake Tahoe, CA


'/>"/>
Contact: Sharon Reis
sreis@gymr.com
202-745-5103
GYMR
Source:Eurekalert

Related biology news :

1. Mitochondrial DNA mutations play significant role in prostate cancer
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
5. Test for early detection of prostate cancer shows promise
6. U-M researchers identify new blood test for prostate cancer
7. U-M scientists say fused genes trigger the development of prostate cancer
8. Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors
9. Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer
10. Virus chip detects new virus in prostate tumors
11. Human prostate grown from embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
(Date:3/18/2016)... , March 18, 2016 --> ... of Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure and ... security companies in the border security market and the continuing ... and Europe has led visiongain to ... improved success. --> defence & security companies ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
Breaking Biology Technology: